{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 23
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "03/21/2023",
      "package_ndc": "25021-115-06",
      "generic_name": "Clindamycin Phosphate Injection",
      "contact_info": "866-625-1618",
      "availability": "Limited Availability",
      "related_info": "Selling through remaining short-dated inventory (Dec 2026).",
      "update_date": "10/08/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Injection",
      "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)",
      "company_name": "Sagent Pharmaceuticals",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "status": "Current"
    }
  ]
}